David Braun (@BraunMDPhD) header
David Braun (@BraunMDPhD) profile picture

Oncologist, physician-scientist @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ≠ medical advice. ASCO FCOI:https://nitter.cf/t.co/IsIqZTpy9c

Yale, New Haven, CT
Joined April 2018
Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)Photo by David Braun (@BraunMDPhD)
1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell What drives exceptional response with immunotherapies? @NatureCancer How do specific immune populations, like NK cells, change in advanced disease? @ESMO_Open How does CD8+ T cell phenotype impact response to anti-PD1 treatment? @CD_AACR Why does chromophobe kidney cancer seemingly have lower responses to immune checkpoint inhibitors? @JCO_ASCO What are immunologically relevant antigen classes in RCC (specifically, ERVs)? @CellCellPress Can we therapeutically target tumor-specific antigens in kidney cancer? @Nature
4
15
4
110
13,562
Proud to see @NazliDizman @DanaFarber on the main stage at @SWOG in our GU planning session. Grateful to @PBarataMD @caseccc (PI of S2419, BIOFRONT) & @BraunMDPhD @YaleCancer (GU translational lead) for getting her involved in analyzing biomarker results in the 1st P3 study evaluating microbiome modulation to improve IO-outcomes!
1
19
80
2,884
While #kidneycancer is slightly more common in men, everyone should be aware of its signs, including blood in the urine and unusual back pain. @BraunMDPhD explains treatment options + insight into new treatments being developed at Yale. ➡️wtnh.com/news/health/who-is-… @YaleCancer
2
2
211
Thank you. Very honored to receive this award from a group that has contributed so much to advance the field, and grateful to me lab, collaborators, and patients and their families. @YaleCancer @YaleMed @SmilowCancer
Congratulations to Dr. David Braun, recipient of the 2026 KidneyCAN Catalyst Award! This award recognizes rising leaders whose innovative research and scientific contributions are helping shape the future of kidney cancer research. We look forward to seeing Dr. Braun's continued impact on the field. Congratulations on this well-deserved recognition! #KCRS26 #AcceleratingCures
7
8
73
3,425
Congratulations to the #WuLab, @BraunMDPhD #GiacomoOliveira and 1st authors @AdiNagler +@AAfeyan @DanaFarber @harvardmed + many colleagues on 2 "same day" papers in @Nature & @NatureBiotech: 1) Tertiary lymphoid structures in Kidney Cancer are reservoirs of tumor-specific T cells with stem-like progenitor features with an interplay with immunosuppressive macrophages that could be leveraged by T cell immunotherapies. 2) New technology: Slide-GoTags that establishes a framework for in situ mapping of T cell–tumor interactions directly from individual tissue.
1
38
1
132
16,592
Congratulations, @BraunMDPhD, on your @kidneycan 2026 Catalyst Award!
6
24
2,546
So proud of @ZiadBakouny and his start @DanaFarber_GU and @VanAllenLab @DanaFarber and @BrighamMedRes —glad you are staying @MSKCancerCenter with friends @DrRosenbergMSK @motzermd @debschrag !
After 15 years of training, excited to be starting as a Genitourinary Oncologist and Instructor @MSKCancerCenter! Very thankful to my wife & daughter who have put up with me during my training, the fellowship program, and all my incredible mentors along the way! @MSK_DeptOfMed
1
10
65
7,847
We are hiring! We are specifically looking for a postgraduate associate - someone who has recently finished university and is ultimately looking to apply to medical school or graduate school. It is a TWO YEAR clinical/translational position, where you will be interacting closely with patients, involved in translational clinical trials, and working hands on in the lab and with clinical databases. The ideal candidate is a great communicator, organized, and enthusiastic about patient-oriented clinical and lab research. You will get dedicated mentoring not just on the science and clinic, but also on career/professional development as well. We are looking for someone to start ASAP! More information here: postdocs.yale.edu/posts/2026… Please help to spread the word and RT! @DrChoueiri @VanAllenLab @tompowles1 @YaleCancer @YaleMed @SmilowCancer @kidneycan @OncoAlert @OncLive @KidneyCancer @A_P_S_A @cure_today @yalepathology @Yale_Urology @DrYukselUrun @MarkDSiegel1 @OncBrothers @DrKarineTawagi
6
61
2
187
37,993
David Braun retweeted
Congratulations to David A. Braun, MD, PhD, recipient of the 2026 Cancer Discovery Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators! Learn more: brnw.ch/21x1INW #AACR26 @BraunMDPhD @YaleCancer @YaleMed @AACR
10
1
30
2,883
Congratulations to @BraunMDPhD, recipient of the @AACR Cancer Discovery Early Career Award, which recognizes outstanding early career investigators who have authored peer-reviewed, original articles published in @CD_AACR. Dr. Braun will formally receive his award during #AACR26. @SmilowCancer @YNHH
1
7
1
41
2,881
Congratulations to @BraunMDPhD, recipient of the #AAIASPIREAward from @ImmunologyAAI, recognizing outstanding early-career scientists advancing immunology research! @SmilowCancer @YaleMed @YNHH
1
8
29
1,765
David Braun retweeted
Replying to @BraunMDPhD
@BraunMDPhD on kidney care advances at event today @YaleCancer @SmilowCancer Read about his amazing vaccine trial results medicine.yale.edu/news-artic…
3
12
910
Looking forward to this event tomorrow! Please register and join us. @kcCURE @KidneyCancer @kidneycan @OncLive @OncBrothers @OncoAlert @TargetedOnc @smart_patients
🚨Reminder🚨 Join us tomorrow at 9am for 'Advancing Care in #KidneyCancer: From Diagnosis to Survivorship,' hosted by @BraunMDPhD ➡️Agenda: bit.ly/4t1t5fZ ➡️RSVP: bit.ly/3OkdSqO @YaleCancer @cure_today @kcCURE @RCCadvocate
1
5
11
2,350
Hello everyone, We are hosting our first kidney cancer symposium in Connecticut for individuals with kidney cancer and their caregivers. Register here: registration.curetoday.com/e… Please re-tweet and help spread the word! @YaleCancer @KidneyCancer @kidneycan @kcCURE @OncBrothers @OncoAlert @DrChoueiri @Uromigos @KidneyCAN4KCRS @OncLive @kaydaustin @smart_patients
Join us Sat., April 11 at 9am for our patient conference: Advancing Care in #KidneyCancer: From Diagnosis to Survivorship, hosted by @BraunMDPhD. 📍 The Greenberg Conference Center, New Haven 🗓 Saturday, April 11, 9am – 2pm ➡️RSVP bit.ly/3OkdSqO @YaleCancer @cure_today @kcCURE @RCCadvocate
2
21
33
5,676
Join us Sat., April 11 at 9am for our patient conference: Advancing Care in #KidneyCancer: From Diagnosis to Survivorship, hosted by @BraunMDPhD. 📍 The Greenberg Conference Center, New Haven 🗓 Saturday, April 11, 9am – 2pm ➡️RSVP bit.ly/3OkdSqO @YaleCancer @cure_today @kcCURE @RCCadvocate
2
2
3
6,195
David Braun retweeted
Truly impressive DFCI GU Oncology team. A special thank you to my host, @DrChoueiri, for a great visit. @mouwlab @VanAllenLab @srviswanathan @bergsa83 @OncoBellmunt @MattMossanen
1
6
2
61
10,244
Honored to serve as discussant for these important RCC oral abstracts: LS-011, RAMPART PRO, and LS-022. 🩵 Together, these studies reflect a bigger theme in RCC: intensification and rational combination therapy across the treatment landscape to improve outcomes, from refractory disease to the adjuvant setting. 📈🧬 I’m excited to approach these data with curiosity, highlight the efficacy signals in today’s clinical context, and dig into the key questions that still remain around patient selection, toxicity, durability, and how best to apply these strategies in practice. 🎯💬 #ASCOGU26 #GU26 #KidneyCancer #RCC #ClinicalTrials
3
7
1
26
1,543